CX 2022 returns to in-person format facing challenges and opportunities in the aortic field

2229
CX returns to an in-person format for 2022

Anticipation is building for the Charing Cross International Symposium 2022 (CX 2022). This will be the first ever hybrid symposium and organisers look forward to welcoming around 2,000 participants in person and up to 6,000 virtually from around 100 countries.

This year the global cardiovascular community challenges the evidence as part of the CX three-year cycle of raising cardiovascular and endovascular controversies to challenge the available evidence in order to reach consensus after discussion with an expert audience. The year’s comprehensive aortic programme will bring together world-leading experts from the cardiovascular, vascular and endovascular worlds including Joseph Bavaria, Gustavo Oderich, Joseph Coselli and Roberto Chiesa.

Click here for full programme, registration and venue details.

Running from 26–28 April, the three-day symposium returns to an in-person format for 2022 in a new transition year location, the Hilton London Metropole in the heart of central London, and features livestream and on-demand viewing options for a global audience. The symposium continues its three-year cycle of raising vascular and endovascular controversies to challenge the available evidence and be able to reach a consensus after discussion with an expert audience.

The programme will include Aortic Challenges and CX Aortic Techniques and Technologies sessions with live and edited live cases. Challenges to practice, in all vascular domains, including peripheral arterial, venous, acute stroke and vascular access will also be explored in live, edited live and workshop demonstrations.

Experts in every field will consider a range of options and weigh up the important issues head-to-head in CX debates.

The aortic programme aims to highlight novel approaches to the most pressing abdominal, thoracic and juxtarenal aortic, as well as radiation, challenges and focus on advancements in the aortic field.

According to Stéphan Haulon (Hôpital Marie Lannelongue, GHPSJ, Paris, France), arch repair is among the important areas for discussion in the aortic space. “The next challenge in the aortic world is the repair of the arch,” Haulon, a member of the CX 2022 aortic executive board, comments, reflecting on the important talking points ahead of the April event. “We now have a couple of devices with three branch options—total endovascular repair of the arch, a percutaneous approach, or to have a less or minimally invasive approach.

“The future will probably be type A dissections. We still do not know if there is a role for endovascular, but it seems that there is a lot of research and development going on and probably, in the near future, we will be able to do Endo-Bentall repairs and acute type A dissections will probably be a subgroup of patients that will benefit from this new technology.”

Tara Mastracci (Barts Health NHS Trust, London, UK) reflects on the importance of developing more accurate fusion technologies and non-ionising radiation guidance. Techniques and technologies aimed at reducing radiation dosage and exposure are set to feature throughout the CX 2022 programme.

“Technically, intraoperatively, getting more accurate fusion technology is something that I am super excited about, and I am excited to learn more about aortic deformation,” says Mastracci. “I cannot wait to see how the technologies emerge for non-ionising radiation guidance and other ways that we can use vessel guidance in the operating room that does not expose us to radiation.”

New techniques to prevent stroke in thoracic endovascular aortic repair (TEVAR) are among the important areas highlighted by Tilo Kölbel (University Heart Center Hamburg, Hamburg, Germany), who also sits on the CX 2022 aortic executive board.

“The most pressing aortic challenges that I look forward to learning more about at CX 2022 and seeing the discussion about new techniques is stroke in TEVAR,” says Kölbel.

“There are some new techniques that make stroke less likely to occur during TEVAR including carbon dioxide flushing. I know that there are new data prepared to be shown at CX 2022 and I look forward to seeing those.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here